XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial Instruments and Fair Value Measurements (Tables)
3 Months Ended
Dec. 28, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Derivatives and Location on Consolidated Balance Sheets
The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:

Derivative InstrumentsHedge DesignationBalance Sheet Location
December 28, 2024
September 28, 2024
Cross-currency swapsDesignated
Other assets
$10 $— 
Schedule of Income or (Loss) from Derivative Instruments
The effect of the Company’s derivative instruments on the Consolidated and Combined Statements of Operations is as follows:
Quarterly Period Ended
Derivative InstrumentsStatements of Income LocationDecember 28, 2024December 30, 2023
Cross-currency swaps
Interest expense
$2 $— 
Schedule of Assets Measured at Fair Value on Non-recurring Basis
Included in the following tables are the major categories of assets and their current carrying values, along with the impairment loss recognized on the fair value measurement for the period then ended:
December 28, 2024
Level 1Level 2Level 3TotalImpairment
Indefinite-lived trademarks$ $ $26 $26 $ 
Goodwill  617 617  
Definite lived intangible assets  233 233  
Property, plant, and equipment  1,532 1,532  
Total$ $ $2,408 $2,408 $ 

September 28, 2024
Level 1Level 2Level 3TotalImpairment
Indefinite-lived trademarks$— $— $26 $26 $— 
Goodwill— — 624 624 (171)
Definite lived intangible assets— — 200 200 (1)
Property, plant, and equipment— — 949 949 — 
Total$— $— $1,799 $1,799 $(172)